TTK HEALTHCARE
|
TTK HEALTHCARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 57.79 | 44.47 | 31.61 | 13.10 | 26.03 |
| CEPS(Rs) | 63.69 | 53.71 | 40.67 | 22.01 | 35.24 |
| DPS(Rs) | 10.00 | 10.00 | 10.00 | 10.00 | 6.00 |
| Book NAV/Share(Rs) | 750.61 | 705.23 | 671.59 | 230.16 | 205.40 |
| Tax Rate(%) | 24.62 | 25.30 | 27.53 | 25.47 | -62.60 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 4.22 | 4.72 | 4.17 | 3.64 | 4.06 |
| EBIT Margin(%) | 13.52 | 10.98 | 8.90 | 4.69 | 5.11 |
| Pre Tax Margin(%) | 13.12 | 10.63 | 8.20 | 4.14 | 4.75 |
| PAT Margin (%) | 9.89 | 7.94 | 5.94 | 3.09 | 7.73 |
| Cash Profit Margin (%) | 10.90 | 9.59 | 7.65 | 5.19 | 10.46 |
| Performance Ratios | |||||
| ROA(%) | 6.60 | 5.31 | 5.20 | 3.56 | 8.04 |
| ROE(%) | 7.94 | 6.46 | 7.01 | 6.02 | 13.76 |
| ROCE(%) | 10.63 | 8.72 | 10.13 | 8.59 | 8.38 |
| Asset Turnover(x) | 0.67 | 0.67 | 0.88 | 1.15 | 1.04 |
| Sales/Fixed Asset(x) | 4.57 | 4.63 | 4.57 | 3.70 | 3.10 |
| Working Capital/Sales(x) | 0.92 | 0.90 | 0.88 | 2.66 | 2.55 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.22 | 0.22 | 0.22 | 0.27 | 0.32 |
| Receivable days | 39.11 | 41.18 | 35.37 | 34.52 | 52.35 |
| Inventory Days | 45.43 | 41.87 | 39.69 | 45.45 | 54.42 |
| Payable days | 103.44 | 114.99 | 112.47 | 130.35 | 160.52 |
| Valuation Parameters | |||||
| PER(x) | 20.72 | 33.35 | 32.71 | 63.29 | 19.00 |
| PCE(x) | 18.80 | 27.61 | 25.42 | 37.68 | 14.03 |
| Price/Book(x) | 1.59 | 2.10 | 1.54 | 3.60 | 2.41 |
| Yield(%) | 0.84 | 0.67 | 0.97 | 1.21 | 1.21 |
| EV/Net Sales(x) | 1.16 | 1.78 | 0.88 | 1.53 | 1.03 |
| EV/Core EBITDA(x) | 8.74 | 13.43 | 8.03 | 24.06 | 16.71 |
| EV/EBIT(x) | 8.30 | 15.45 | 9.56 | 32.71 | 20.09 |
| EV/CE(x) | 0.86 | 1.32 | 0.66 | 1.67 | 1.00 |
| M Cap / Sales | 2.11 | 2.78 | 2.01 | 1.96 | 1.47 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 6.47 | 3.82 | 21.01 | 25.88 | -26.28 |
| Core EBITDA Growth(%) | 6.15 | 25.42 | 108.76 | 30.47 | -21.08 |
| EBIT Growth(%) | 28.52 | 29.91 | 138.20 | 15.38 | 7.22 |
| PAT Growth(%) | 29.94 | 40.69 | 141.32 | -49.68 | 198.57 |
| EPS Growth(%) | 29.94 | 40.69 | 141.31 | -49.68 | 198.57 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.02 | 0.03 | 0.06 | 0.06 |
| Current Ratio(x) | 5.23 | 5.35 | 5.06 | 2.13 | 1.99 |
| Quick Ratio(x) | 4.72 | 4.86 | 4.66 | 1.74 | 1.62 |
| Interest Cover(x) | 33.59 | 31.53 | 12.76 | 8.67 | 14.22 |
| Total Debt/Mcap(x) | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
Compare Financial Ratios of peers of TTK HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TTK HEALTHCARE | ₹1,626.3 Cr | -3.4% | -4.3% | -25.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,791.0 Cr | 1.2% | 4.2% | -10.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,885.0 Cr | -0.5% | 8.9% | 10.8% | Stock Analytics | |
| CIPLA | ₹127,930.0 Cr | 0.4% | 3.7% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹121,108.0 Cr | -0% | -2.1% | 6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,164.0 Cr | 2.2% | -1.8% | -4.4% | Stock Analytics | |
TTK HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TTK HEALTHCARE | -3.4% |
-4.3% |
-25.7% |
| SENSEX | 0.9% |
2.5% |
3.7% |
You may also like the below Video Courses
